In this cross-sectional study, we compared the quality of life (QOL) in transfusion-dependent thalassemic patients who survived matched sibling hematopoietic SCT (HSCT, n = 24) with patients treated conventionally with transfusion and iron chelation (n = 74). WHOQOL-BREF(HK) and PedsQL questionnaires were administered to patients aged >18 years and 5-12 years, respectively. Patients aged 12-18 years received both questionnaires. WHOQOL-BREF(HK) revealed post transplant patients rated overall health better than those treated conventionally (score 3.67 vs 3.06, P = 0.01). They are less dependent on medical aids (3.87 vs 2.96, P = 0.006), having higher activity level (4.00 vs 3.36, P = 0.026) and better personal relationships (4.13 vs 3.69, P ...
Bone marrow transplantation (BMT) represents a potentially curative treatment of thalassemia. For pa...
It is well known that patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT)...
Thalassemia is the most common hemoglobin disorder in the world and thalassemia major and intermedia...
In this cross-sectional study, we compared the quality of life (QOL) in transfusion-dependent thalas...
The principal aim of our study was to investigate whether patients transplanted more than 20 years a...
Although hematopoietic stem cell transplantation (HSCT) has been widely used to treat pediatric pati...
Although hematopoietic stem cell transplantation (HSCT) has been widely used to treat pediatric pati...
Thalassemia major is a chronic, progressive hemoglobin disorder requiring life-long transfusion and ...
Thalassemia major is a chronic, progressive hemoglobin disorder requiring life-long transfusion and ...
Background and aims: Nowadays introduction of regular blood transfusion therapy has obviously improv...
In total, 124 adult patients in remission after allogeneic hematopoietic SCT (HSCT) participated in ...
AbstractSickle cell disease (SCD) is a hereditary hemoglobinopathy that affects over 100,000 people ...
Background The treatment of children with transfusion-dependent thalassemia (TDT) in Malaysia has pr...
Identifying factors that predict health-related quality of life (QOL) following hematopoietic SCT, i...
Factors associated with changes in quality of life in patients undergoing allogeneic haematopoietic ...
Bone marrow transplantation (BMT) represents a potentially curative treatment of thalassemia. For pa...
It is well known that patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT)...
Thalassemia is the most common hemoglobin disorder in the world and thalassemia major and intermedia...
In this cross-sectional study, we compared the quality of life (QOL) in transfusion-dependent thalas...
The principal aim of our study was to investigate whether patients transplanted more than 20 years a...
Although hematopoietic stem cell transplantation (HSCT) has been widely used to treat pediatric pati...
Although hematopoietic stem cell transplantation (HSCT) has been widely used to treat pediatric pati...
Thalassemia major is a chronic, progressive hemoglobin disorder requiring life-long transfusion and ...
Thalassemia major is a chronic, progressive hemoglobin disorder requiring life-long transfusion and ...
Background and aims: Nowadays introduction of regular blood transfusion therapy has obviously improv...
In total, 124 adult patients in remission after allogeneic hematopoietic SCT (HSCT) participated in ...
AbstractSickle cell disease (SCD) is a hereditary hemoglobinopathy that affects over 100,000 people ...
Background The treatment of children with transfusion-dependent thalassemia (TDT) in Malaysia has pr...
Identifying factors that predict health-related quality of life (QOL) following hematopoietic SCT, i...
Factors associated with changes in quality of life in patients undergoing allogeneic haematopoietic ...
Bone marrow transplantation (BMT) represents a potentially curative treatment of thalassemia. For pa...
It is well known that patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT)...
Thalassemia is the most common hemoglobin disorder in the world and thalassemia major and intermedia...